Syntax Bio
Synthetic biology company programming stem cells
Chicago, United States · Founded 2021 · $15.0M raised
- Headquarters
- Chicago, Illinois
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- syntax-bio.com
- Total Funding
- $15.0M
- Last Round
- $15.0M SeedSep 2024
- Rounds
- 1
About
Develops a CRISPR-based platform to program and accelerate stem cell differentiation, enabling scalable regenerative cell therapies for biopharma partners.
Summary
Syntax Bio is a Biotech company based in Chicago, United States, founded in 2021. It has raised $15.0M in total across 1 round, most recently a $15.0M Seed round in Sep 2024. Investors include Astellas Venture Management, Illumina Ventures and DCVC (Data Collab).
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2024
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/syntax-bio"><img src="https://indexed.vc/api/badge/company/syntax-bio" alt="Syntax Bio on Indexed.vc" width="260" height="76" /></a>